Načítá se...
Bromocriptine and insulin sensitivity in lean and obese subjects
Bromocriptine is a glucose-lowering drug, which was shown to be effective in obese subjects with insulin resistance. It is usually administered in the morning. The exact working mechanism of bromocriptine still has to be elucidated. Therefore, in this open-label randomized prospective cross-over mec...
Uloženo v:
| Vydáno v: | Endocr Connect |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Bioscientifica Ltd
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5097144/ https://ncbi.nlm.nih.gov/pubmed/27758845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-16-0051 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|